Hanmei Lou

A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC).

Jing Wang, Hanmei Lou, Hongbing Cai et al. · Journal of Clinical Oncology · 2022 · 40 citations

Metastatic Cervical Cancer, Cervical Cancer, Ak104 Monotherapy +13

<p>Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer</p>

Zhuomin Yin, Huarong Tang, Li Li et al. · Cancer Management and Research · 2019 · 33 citations · Full text

Distribution of HPV Genotype in Invasive Cervical Carcinoma and Cervical Intraepithelial Neoplasia in Zhejiang Province, Southeast China: Establishing the Baseline for Surveillance

Xiaoxian Xu, Jiansong Zhou, Shuhui Yuan et al. · International Journal of Environmental Research and Public Health · 2015 · 25 citations · Full text

Invasive Cervical Cancer, Epidemiology Of Cancer, Gynecology +20

Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery

Xiaojing Zhang, Zunfu Lv, Xiaoxian Xu et al. · BMC Cancer · 2020 · 24 citations · Full text

Ovarian preservation in adenocarcinoma of the uterine cervix

Jiansong Zhou, Yuanyuan Chen, Zhang Ping et al. · Journal of Ovarian Research · 2017 · 22 citations · Full text